Phesi Releases New Data Highlighting Impact from War in Ukraine


New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development. Phesi analyzed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities. The findings show that as of March 16, 2022, there were 65,593 recruiting investigator sites globally in this category. Of these, 2,911 (4.4%) sites were based in Ukraine and Russia, with the majority of pharmaceutical trials currently in Phase III.

Read more about this data release from Phesi here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.